Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Gowling WLG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2740806

Filing Date : 2009-12-08

Strength per Unit : 1200mg / 20ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

blank

02

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2925310

Filing Date : 2014-09-26

Strength per Unit : 1200mg / 20ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

blank

03

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2905798

Filing Date : 2014-03-12

Strength per Unit : 1200mg / 20ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

blank

04

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2740806

Filing Date : 2009-12-08

Strength per Unit : 840mg / 14ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

blank

05

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2925310

Filing Date : 2014-09-26

Strength per Unit : 840mg / 14ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

blank

06

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Patent Number : 2905798

Filing Date : 2014-03-12

Strength per Unit : 840mg / 14ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

blank

07

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ SC

Patent Number : 2905798

Filing Date : 2014-03-12

Strength per Unit : 125 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2034-03-12

Date Granted : 2023-01-24

blank

08

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ SC

Patent Number : 2925310

Filing Date : 2014-09-26

Strength per Unit : 125 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2034-09-26

Date Granted : 2022-12-06

blank

09

Gowling WLG

arrow
Pharmaconex
Not Confirmed

Gowling WLG

Country
arrow
Pharmaconex
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ SC

Patent Number : 2740806

Filing Date : 2009-12-08

Strength per Unit : 125 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-12-08

Date Granted : 2021-07-20

blank